OmniPathology Launches OmniClassroom, a COVID School Testing Program for Greater Los Angeles Schools

PASADENA, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — OmniPathology today launches its school COVID PCR testing program, OmniClassroom.

As schools prepare to reopen, OmniClassroom offers a comprehensive program that allows schools to test staff, students, and families using Omni’s PCR testing. OmniClassroom provides test kits to Los Angeles-area schools, coordinates testing on-campus, and samples are returned to OmniPathology to be tested and resulted within 24 hours. The Omni-COVID-19 Test uses real-time RT-PCR technology to detect SARS-CoV-2, the virus causing the COVID-19 pandemic. The test is performed on nasal swabs.

“As an organization that is led by science and driven by service, we have worked diligently since the beginning of the COVID crisis to help our community deal with various challenges. Our commitment to 24-hour delivery of test results has become an industry standard. Our vision is to help schools perform testing in an efficient and organized way ensuring seamless sampling without disruption of normal school activities. Through our partnerships with nursing organizations, we help schools schedule on-campus testing events. Furthermore, we invested in electronic solutions that facilitate result delivery to schools and families in an efficient and HIPPA-compliant fashion,” said Mohammad Kamal, MD Founder and CEO of OmniPathology.

OmniClassroom is a flexible program designed to offer testing based on each school’s needs as far as the number and frequency of testing. OmniPathology staff provides the necessary tools, including consent forms, access to results through a web portal, and delivery of results through text messages. There are no out-of-pocket costs since testing is covered by insurance. Testing for uninsured individuals will be billed through the CARES Act.

About OmniPathology:

OmniPathology is a physician-owned high complexity pathology laboratory located in Pasadena, California. It specializes in Gastrointestinal pathology, GYN and male health and provides state-of-the-art molecular and cytogenetic testing to complement its pathology and immunohistochemistry testing with specific focus on screening and early detection of anal, cervical, colon and esophageal cancers. OmniPathology’s infectious menu includes HPV, other STD and gynecological, gastrointestinal and respiratory infectious panels. Omni-COVID-19 PCR test received FDA Emergency Use Authorization (EUA) in June 2020.

Contact:

Tom Woolf
Director, Public Relations
Gumas Advertising
[email protected], 415.621.7575



Conduent and Experian Health™ Team Up to Speed Patient Access to Prescription Drug Assistance during Pandemic and Beyond

Conduent’s expertise with Patient Assistance Programs (PAPs) expedites drug therapies for uninsured and underinsured patients improving health amid high unemployment and uncertainty

FLORHAM PARK, N.J., Nov. 17, 2020 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a business process services and solutions company, has announced a commercial agreement with Experian Health, a leading provider of revenue cycle management products that include patient engagementpatient access and patient collections. The agreement enables Conduent’s digital IntelliHealthplatform to connect with Experian’s consumer data and electronic income verification tool to speed prescription drug assistance approvals and shorten prescription fulfillment and time to therapy.

The collaboration is expected to streamline access to free prescription drug assistance benefiting up to 28 million Americans with no or limited healthcare coverage, and more than 12.6 million Americans reported to be jobless by the Bureau of Labor Statistics.

Healthcare Patient Benefits

Every year over $13 billion worth of prescription medicines are provided at no cost to people who can’t afford their medications. To qualify for free prescription drugs, PAP applicants must demonstrate financial need by submitting evidence of family income, family size, and if applicable, their healthcare financial burden. Now patients have a quick and easy paperless proof of income option that eliminates the need for W-2 or tax return submission. Experian’s Patient Financial Clearance leverages credit bureau-exclusive predictors and verified income data to deliver real-time income estimation of all household income.

“Combining Conduent’s patient access technology with Experian’s data now provides a complete financial picture that can validate patient demographics in seconds and greatly improves delivery of patient assistance program services during a time of high need,” said Anthony Bianchini, General Manager Conduent Pharma Life Sciences. “The addition of Experian’s financial data tool aligns seamlessly with our continuing commitment to making healthcare more accessible, affordable, and effective for all.”

“Experian has a 40-year history of using data for good and our work with Conduent furthers that mission,” said Matt McGrath, Vice President of Pharmacy Strategy at Experian Health. “Our solution eliminates requiring a patient to locate and provide financial records, allowing the focus to be on recovery instead of worrying about how to obtain the right treatment.”
  
For the past 30 years, Conduent has helped the nation’s leading pharmaceutical companies deliver patient assistance programs that help countless patients get access to the medications they need, while reducing physician administrative burdens. Learn more at https://www.conduent.com/healthcare-solutions/.

About Conduent


Conduent delivers mission-critical services and solutions on behalf of businesses and governments – creating exceptional outcomes for its clients and the millions of people who count on them. Through our dedicated people, process and technology, Conduent solutions and services automate workflows, improve efficiencies, reduce costs and enable revenue growth. It’s why most Fortune 100 companies and over 500 government entities depend on Conduent every day to manage their essential interactions and move their operations forward.

Conduent’s differentiated services and solutions improve experiences for millions of people every day, including two-thirds of all insured patients in the U.S., 10 million employees who use its HR Services, and nearly 18 million benefit recipients. Conduent’s solutions deliver exceptional outcomes for its clients, including $17 billion in savings from medical bill review, up to 40% efficiency increase in HR operations, up to 27% reduction in government benefits costs, up to 40% improvement in finance, accounting and procurement expense, and improved customer service interaction times by up to 20% with higher end-user satisfaction. Learn more at www.conduent.com.

About Experian Health


At Experian Health, we serve more than 60 percent of U.S. hospitals and more than 7,700 medical practices, labs, pharmacies and other risk-bearing entities with data-driven platforms and insights that empower our clients to make smarter business decisions, deliver a better bottom line and establish strong patient relationships. We are part of Experian, the world’s leading global information services company, providing us access to deep data and analytics capabilities that complement the strong healthcare heritage rooted in our legacy companies. Our industry-leading solutions span revenue cycle management, identity management, patient engagement, and care management. Experian’s strength comes from more than 17,800 people operating across 45 countries, and every day we’re investing in new technologies, world class talent and innovations that help our clients maximize every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

For more information about Experian Health, visit http://www.experianhealth.com.

Media Contact
s
:

Jennifer Wadsworth, Conduent, +1-678-488-2806, [email protected]

Investor Relations Contact
s
:

Alan Katz, Conduent, +1-973-526-7173, [email protected]
Rebecca Koar, Conduent, +1-862-308-7105, [email protected]

Note: To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.
Conduent is a trademark of Conduent Incorporated in the United States and/or other countries.



Uber and AU10TIX Launch New Safety Measures for Cash-Paying Riders

Identification Technology Strengthens Trust Between Riders and Driving Partners

PR Newswire

HOD HASHARON, Israel, Nov. 17, 2020 /PRNewswire/ — Uber Technologies, Inc. (NYSE: UBER) has partnered with AU10TIX, a global identity verification and authentication platform, to implement a program in cities in Mexico, Argentina and Chile that helps verify the identity of new riders who choose cash as their preferred method of payment. The program leverages AU10TIX’s proprietary technology to build trust between rider and driver.

The new program requires certain users who request to pay in cash to scan an official identification such as their voting credentials, national ID, passport or driver’s license for verification.

“In the current business climate, more drivers and riders are wanting added reassurance for  cash payment options, and we want to give them that,” says Ron Atzmon, AU10TIX active deputy chairman. “Working together with Uber, we are delivering on this with AU10TIX’s identity document verification technology that provides the reliability, efficiency and scalability required to help provide peace of mind.”

Uber and AU10TIX first partnered in 2019, with Uber’s core rideshare service, and recently expanded their partnership to electric scooters and Uber Eats.

“As COVID-19 has shifted priorities for both Uber and AU10TIX, our partnership with Uber has also evolved,” says Carey O’Connor Kolaja, AU10TIX’s CEO. “Together, we worked on a platform that brings together payment preference and identity verification to prioritize safety for both riders and drivers. We expect this launch to set the stage for us to expand into other countries where Uber is experiencing elevated demand for cash payments.”

Uber and AU10TIX’s latest partnership represents the future of adaptive identity verification. It demonstrates how identity proofing can adjust to a consumer payment preference. Cash, for example, is important to accept, and will drive an increase in layers of verification.

About Uber
Uber’s mission is to create opportunity through movement. We started in 2010 to solve a simple problem: how do you get access to a ride at the touch of a button? More than 15 billion trips later, we’re building products to get people closer to where they want to be. By changing how people, food, and things move through cities, Uber is a platform that opens up the world to new possibilities.

About AU10TIX
AU10TIX, an identity management company headquartered in Israel, provides critical, modular solutions to link physical and digital identities so that companies and their customers can confidently connect. Over the last decade, AU10TIX has become the preferred partner for customer onboarding and customer verification automation and we continue to work on the edge of what’s next for the future of identity’s role in society. Our proprietary technology provides results in less than 8 seconds, allowing companies to onboard faster, prevent fraud, meet compliance mandates, and, importantly, establish trust with their customers. We recently announced an $80M investment from TPG and Oak ft/hc to fuel growth and innovation. AU10TIX is a subsidiary of ICTS International N.V. (OTCQB: ICTSF). For more information, visit AU10TIX.com.

Media Contact

AU10TIX

Joseph Giumarra


[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/uber-and-au10tix-launch-new-safety-measures-for-cash-paying-riders-301174822.html

SOURCE AU10TIX

Syneos Health Names Larry A. Pickett Jr. Chief Information & Digital Officer

MORRISVILLE, N.C., Nov. 17, 2020 (GLOBE NEWSWIRE) — Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Larry A. Pickett, Jr. as Chief Information & Digital Officer. Pickett will lead the global Business Technology team, oversee the Company’s Dynamic Assembly open architecture technology network and manage the creation of new technology and data-enabled products.

“We believe Larry’s vast biopharmaceutical technology and data expertise will add tremendous value to our end-to-end product development model,” said Jason Meggs, Chief Financial Officer, Syneos Health. “His unique IT leadership background, combined with his development of entrepreneurial, revenue generating biopharmaceutical products, makes him the ideal match for our organization. I’m excited to see first-hand what this powerful combination produces for our colleagues, customers and the patients they serve.”

Pickett is a senior leader with 30 years of technology, process and P&L expertise, leading large, enterprise-wide technology initiatives and innovative biopharmaceutical product introductions. He was most recently the co-founder and CEO of RxDataScience, a healthcare data analytics startup based in Research Triangle Park, New York City, and London. Prior to founding RxDataScience, he served as CIO at Purdue Pharma and held senior IT positions at Merck, Glaxo, and GE.

“There is an ever-evolving amount of healthcare data being generated across the clinical to commercial continuum,” commented Pickett. “Syneos Health is the only end-to-end company positioned to unlock the value of this data, sharing insights that can ultimately save lives. I look forward to helping lead this discovery process and taking part in this life-changing work.”

Syneos Health curates an open and highly flexible technology architecture built with the best-of-breed, most aligned data and technology partners as opposed to creating and relying solely on in-house technologies or solutions. This fluid, multiple-option strategy – called Dynamic Assembly – addresses the nuances of each customer, trial protocol and product launch quickly rather than being forced to bend legacy assets to a task for which they weren’t originally designed. 

About Syneos Health

Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Our Company brings together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com

Contacts

Investor Relations:

Ronnie Speight
Senior Vice President, Investor Relations
+1 919 745 2745
[email protected]

Press/Media:

Danielle DeForge
Vice President, External Communications
+1 202 210 5992
[email protected]



IRSA Inversiones y Representaciones S.A. Announces that it has filed its 20F Form for FY 2020 ended June 30, 2020

PR Newswire

BUENOS AIRES, Argentina, November 17, 2020 /PRNewswire/ — IRSA Inversiones y Representaciones S.A. (NYSE: IRS; ByMA: IRSA), the leading real estate company in Argentina, announces that it has filed with the SEC the 20F Form for Fiscal Year 2020 ended June 30, 2020.

The document has been uploaded on the Company’s website www.irsa.com.ar and shareholders have the ability to receive a hard copy of the complete audited financial statements free of charge upon request.

To read the 20F please click here

IRSA Inversiones y Representaciones S.A. (NYSE: IRS, BYMA: IRSA) is Argentina’s largest, most well-diversified real estate company, and it is the only company in the industry whose shares are listed on both the BYMA and The New York Stock Exchange. Through its subsidiaries, IRSA manages an expanding top portfolio of shopping centers and office buildings, primarily in Buenos Aires. The company also owns three luxury hotels. Additionally, IRSA owns a stake in Banco Hipotecario, Argentina’s largest mortgage supplier in the country.

Investor Relations Department
IRSA Inversiones y Representaciones S.A.
+ 5411 4323-7449
[email protected] 
www.irsa.com.ar 
Follow us on Twitter @irsair

 

Cision View original content:http://www.prnewswire.com/news-releases/irsa-inversiones-y-representaciones-sa-announces-that-it-has-filed-its-20f-form-for-fy-2020-ended-june-30-2020-301174814.html

SOURCE IRSA Inversiones y Representaciones S.A.

IIROC Trading Halt – NBY

Canada NewsWire

VANCOUVER, BC, Nov. 17, 2020 /CNW/ – The following issues have been halted by IIROC:

Company: Niobay Metals Inc.

TSX-Venture Symbol: NBY

All Issues: Yes

Reason: At the Request of the Company Pending News

Halt Time (ET): 8:28 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Arizona’s Prop 207 Passes to Legalize Recreational Cannabis in Arizona while American Green (ERBB) Makes Progress to Triple its Cannabis Production in 2021

PR Newswire

PHOENIX, Nov. 17, 2020 /PRNewswire/ — Today American Green’s (OTC: ERBB) president, David Gwyther announced today that cannabis recreational use has finally come to Arizona following the overwhelming passage of  Arizona’s Proposition 207 – the measure that legalizes recreational use of cannabis throughout the state.  Coupled with the President-elect’s promise to decriminalize cannabis on a federal level, American Green believes that this coming year is shaping up to be its best year yet. 

American Green has identified several prospective cultivation sites in the Phoenix area and anticipates keeping its shareholders and other interest-holders informed of its property selection as the process progresses. “We anticipated recreational use happening in Arizona for the past 2 years, and the timing of the AZ bill’s passage couldn’t have worked out better for the company,” said David Gwyther, American Green’s president and chairman. 

According to its grow division manager, American Green doesn’t just grow cannabis…the company delivers some of the best cannabis available in Arizona on behalf of its licensor.  With few exceptions (for security purposes) the American Grow Operation can be viewed LIVE every weekday by going to https://americangreen.com/live/ on your web browser. The grow is also available by going to YouTube or by clicking HERE. (Be sure to subscribe)

The Company now plans to ask our State’s Congressional Delegation to consider federally legalizing cannabis, even if the bill included the ability of states who are not willing to go along to exempt themselves from the regulation if they so desired  – similar to the legislation that passed to end prohibition.

The company’s news on Oct 28th announcing its plan to triple its current cannabis production under American Green’s management seems perfectly timed. Since the company’s recently announced search to expand in late October,

In other news, The American Green CBD Emporium is well stocked with some very high quality CBD offerings – all at very reasonable prices with its Thanksgiving Specials. Check out American Green’s newest product offerings including its: 50mg CBD Capsules (Sleep Formula), 25mg Water Soluble Powder (10 Pack) and our 1000mg CBD Balm. Or, shop our top selling products (based on order frequency) which include our CBD Capsules, CBD Oils and CBD Pet Treats.

Why Shop American Green?

  • Free Shipping On All Orders
  • Large Selection of Products (over 140 items and growing)
  • 100% USA Made Products
  • All Products are THC-FREE (they contain 0.00% THC)
  • 20% Discount For Shareholders (promo code INVESTOR)
  • Weekly Deals (new deals every week)

American Green accepts: Visa, MasterCard, American Express, Discover, and Diners Club (which are securely processed in the USA).

Shareholders and interest holders may also stay current with American Green Updates:

American Green’s Main Website at www.americangreen.com

Twitter:  @American__Green (two underscores), or

Facebook: https://www.facebook.com/americangreenusa
Instagram: https://www.instagram.com/americangreenusa/
Instagram: https://www.instagram.com/magicalnipton/

About American Green, Inc.

American Green, Inc. became, in 2009, America’s second publicly-traded company in the cannabis industry. American Green now, with its more than 50,000 certified beneficial shareholders, is one of the largest (in shareholder count)  in the cannabis sector. American Green’s mission is to lead the cannabis and premium CBD industry. Leveraging our team of professionals in cultivation management, manufacturing, extraction, wholesale, retail, and community outreach, we strive to develop sustainable initiatives in the cannabis-adjacent and CBD industries, laser-focused on adding company and shareholder value.

For more information –

Contact:
American Green, Inc.
Investor Relations
2902 W. Virginia Ave
Phoenix, AZ  85009
480-443-1600 X555
[email protected]

NOTES ABOUT FORWARD-LOOKING STATEMENTS

Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company’s Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, be should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.

Cision View original content:http://www.prnewswire.com/news-releases/arizonas-prop-207-passes-to-legalize-recreational-cannabis-in-arizona-while-american-green-erbb-makes-progress-to-triple-its-cannabis-production-in-2021-301174811.html

SOURCE American Green, Inc.

RE/MAX National Housing Report for October 2020

Homes Sell at Fastest Pace in Over a Decade

PR Newswire

DENVER, Nov. 17, 2020 /PRNewswire/ — For the first time since 2009, homes sold faster in October than the preceding summer peak season, according to the RE/MAX National Housing Report. And across 52 markets, the average of 38 days from listing to contract marked the fastest pace of any month in the report’s 13-year history.

Defying seasonality in a year upended by the pandemic, October sales were the third-highest year-to-date. Home sales were slightly up compared to September 2020 (+0.1%), and 20.8% ahead of October 2019. The Median Sales Price of $295,000, which was 0.9% higher than September’s median price and 15.4% higher year-over-year, set a report record for October.

“The housing market continued its remarkable run in October, driven by high demand and historically low interest rates. Buyers, many of them freed from the constraints of having to live close to work, are jumping into the market and looking for homes that have what they want – a home office, more outdoor space, or whatever else it might be,” said Adam Contos, CEO of RE/MAX Holdings, Inc.

“The short turnaround times are telling, too. Buyers are ready to act as soon as they see the right home. Sellers who want to get through the process quickly, without having to move much on price, have a great opportunity to do so right now. That advantage should bring more listings into the market in the months ahead, but with inventory levels as low as they are, it will likely be a while before we see anything resembling a balanced market.”

Reflecting an abundance of home buyers and a shortage of sellers, inventory fell 32.5% year-over-year to set another report record.

October’s average Days on Market of 38 was one day less than September and down 11 days year-over-year. The average Months Supply of Inventory at 1.7 tied July and August for the smallest in report history, with a handful of markets reporting less than a one-month supply.

Highlights and the local markets leading various metrics include:

Closed Transactions 

Of the 52 metro areas surveyed in October 2020, the overall average number of home sales was up 0.1% compared to September 2020, and up 20.8% compared to October 2019.  Leading the year-over-year sales percentage increase were Hartford, CT at +41.3%, Wichita, KS at +33.9%, and Chicago, IL at +33.4%.

Median Sales Price – Median of 52 metro median prices

In October 2020, the median of all 52 metro Median Sales Prices was $295,000, up 0.9% from September 2020, and up 15.4% from October 2019. No metro area saw a year-over-year decrease in Median Sales Price. Forty-eight metro areas increased year-over-year by double-digit percentages, led by Augusta, ME at +29.1%, Tulsa, OK at +20.5%, and Cincinnati, OH at +20.4%.

Days on Market – Average of 52 metro areas

The average Days on Market for homes sold in October 2020 was 38, down one day from the average in September 2020, and down 11 days from the average in October 2019. The metro areas with the lowest Days on Market were Cincinnati, OH at 18, Boise, ID at 20, and Nashville, TN at 21. The highest Days on Market averages were in Miami, FL at 89, Des Moines, IA at 86, and New York, NY at 74. Days on Market is the number of days between when a home is first listed in an MLS and a sales contract is signed.

Months Supply of Inventory – Average of 52 metro areas

The number of homes for sale in October 2020 was down 7.6% from September 2020 and down 32.5% from October 2019. Based on the rate of home sales in October 2020, the Months Supply of Inventory decreased to 1.7 compared to 1.9 in September 2020, and decreased compared to 3.6 in October 2019. A six months supply indicates a market balanced equally between buyers and sellers. In October 2020, of the 52 metro areas surveyed, zero metro areas reported a months supply at or over six, which is historically considered a buyer’s market. The markets with the lowest Months Supply of Inventory were Boise, ID at 0.5, a two-way tie between Albuquerque, NM and Manchester, NH at 0.7, and a four-way tie between Phoenix, AZ, Charlotte, NC, Denver, CO, and Omaha, NE at 0.9.

For specific data in this report or to request an interview, please contact [email protected].

About the RE/MAX Network

As one of the leading global real estate franchisors, RE/MAX, LLC is a subsidiary of RE/MAX Holdings (NYSE: RMAX) with over 135,000 agents in more than 110 countries and territories. Nobody in the world sells more real estate than RE/MAX, as measured by residential transaction sides. Dedicated to innovation and change in the real estate industry, RE/MAX launched Motto Mortgage, a ground-breaking mortgage franchisor, in 2016 and acquired booj, a real estate technology company, in 2018. RE/MAX agents have lived, worked and served in their local communities for decades, raising millions of dollars every year for Children’s Miracle Network Hospitals® and other charities. To learn more about RE/MAX, to search home listings or find an agent in your community, please visit www.remax.com. For the latest news about RE/MAX, please visit news.remax.com

Description

The RE/MAX National Housing Report is distributed each month on or about the 15th. The first Report was distributed in August 2008. The Report is based on MLS data in approximately 52 metropolitan areas, includes all residential property types, and is not annualized. For maximum representation, many of the largest metro areas in the country are represented, and an attempt is made to include at least one metro from each state. Metro area definitions include the specific counties established by the U.S. Government’s Office of Management and Budget, with some exceptions.

Definitions

Transactions are the total number of closed residential transactions during the given month. Months Supply of Inventory is the total number of residential properties listed for sale at the end of the month (current inventory) divided by the number of sales contracts signed (pended) during the month. Where “pended” data is unavailable, this calculation is made using closed transactions. Days on Market is the number of days that pass from the time a property is listed until the property goes under contract for all residential properties sold during the month. Median Sales Price is the median of the median sales prices in each of the metro areas included in the survey.  

MLS data is provided by contracted data aggregators, RE/MAX brokerages and regional offices. While MLS data is believed to be accurate, it cannot be guaranteed. MLS data is constantly being updated, making any analysis a snapshot at a particular time. Every month the RE/MAX National Housing Report re-calculates the previous period’s data to ensure accuracy over time. All raw data remains the intellectual property of each local MLS organization.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/remax-national-housing-report-for-october-2020-301174259.html

SOURCE RE/MAX, LLC

Protech Home Medical to Webcast Live at VirtualInvestorConferences.com December 3rd

Protech invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

PR Newswire

CINCINNATI, Nov. 17, 2020 /PRNewswire/ — Protech Home Medical Corp. (“Protech” or the “Company“) (TSXV: PTQ), (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that Greg Crawford, CEO, will present live at VirtualInvestorConferences.com on December 3rd at 11am EDT.   

DATE: December 3rd, 2020

TIME: 11:00am EDT

LINK: 
https://bit.ly/3k2oLZh

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.


About Protech Home Medical

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.


About Virtual Investor Conferences

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/protech-home-medical-to-webcast-live-at-virtualinvestorconferencescom-december-3rd-301174702.html

SOURCE VirtualInvestorConferences.com

Rand Capital Makes Largest Initial Funding of $3.8 Million with Caitec Inc.

Rand Capital Makes Largest Initial Funding of $3.8 Million with Caitec Inc.

BUFFALO, N.Y.–(BUSINESS WIRE)–Rand Capital Corporation (Nasdaq: RAND) (“Rand”), a business development company, today announced that it recently funded an initial investment in Caitec Inc., a rapidly growing provider of specialty pet products. Rand invested $3.5 million through a 14% subordinated secured note and an additional $300,000 in Class A Preferred stock.

Allen F. (“Pete”) Grum, President and Chief Executive Officer, noted, “The investment in Caitec represents a key transition point for Rand, as it represents one of the largest initial financings into a business in our history. While the investment follows our long-standing model of investing in quality management teams, the growth stage nature and size of this investment make this financing stand out. The debt portion of the investment will provide approximately $490,000 of income to Rand annually. This illustrates our strategy to transform into an income producing BDC, while also continuing our longstanding capital appreciation strategies through the equity co-investment in the business. We feel that this investment provides the best attributes of strong current income combined with the potential for long-term capital gain. We are pleased to support Caitec’s growth strategy as it expands its product offerings and channels to market.” Rand participated in this financing with Fairchild Capital Partners, LLC.

Caitec, based in Halethorpe, Maryland, is a leading manufacturer and distributor of toys for dogs, various products for pet birds, and other supplies for the burgeoning pet industry. The Company’s products are offered globally via a variety of sales channels, including national and local pet retailers, mass and regional retailers, grocery stores, and e-commerce. Caitec offers products through their own proprietary brands, as well as private label brands. The Company’s brands include Hero, Chase ‘N Chomp, Featherland Paradise, Oven Fresh Bites, Nature’s Instinct, and TitanEze.

Rand’s investment objective is to focus primarily on income accreting investments as it deploys $22 million of available liquidity.

ABOUT RAND CAPITAL

Rand Capital (Nasdaq: RAND) is an externally-managed Business Development Company (BDC) with a wholly-owned subsidiary licensed by the U.S. Small Business Administration (SBA) as a Small Business Investment Company (SBIC). The Company’s investment objective is to maximize total return to its shareholders with current income and capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. Rand invests in early to later stage businesses that have sustainable, differentiated and market-proven products, revenue of more than $2 million and a path to free cash flow or up to $5 million in EBITDA. The Company’s investment activities are managed by its external investment adviser, Rand Capital Management, LLC. Additional information can be found at the Company’s website where it regularly posts information: https://www.randcapital.com/.

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than historical facts, including but not limited to statements regarding the effectiveness of Rand’s new investment strategy; the ability to deploy its investment capital; the competitive ability and position of Rand; and any assumptions underlying any of the foregoing, are forward-looking statements. Forward-looking statements concern future circumstances and results and other statements that are not historical facts and are sometimes identified by the words “may,” “will,” “should,” “potential,” “intend,” “expect,” “endeavor,” “seek,” “anticipate,” “estimate,” “overestimate,” “underestimate,” “believe,” “could,” “project,” “predict,” “continue,” “target” or other similar words or expressions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) evolving legal, regulatory and tax regimes; (2) changes in general economic and/or industry specific conditions; and (3) other risk factors as detailed from time to time in Rand ’s reports filed with the Securities and Exchange Commission (“SEC”), including Rand’s annual report on Form 10-K for the year ended December 31, 2019, quarterly reports on Form 10-Q, and other documents filed with the SEC. Consequently, such forward-looking statements should be regarded as Rand’s current plans, estimates and beliefs. Except as required by applicable law, Rand assumes no obligation to update the forward-looking information contained in this release.

Company:

Allen F. (“Pete”) Grum

President and CEO

Phone: 716.853.0802

Email: [email protected]

Investors:

Deborah K. Pawlowski

Kei Advisors LLC

Phone: 716.843.3908

Email: [email protected]

KEYWORDS: New York Maryland United States North America

INDUSTRY KEYWORDS: Professional Services Retail Consumer Specialty Pets Finance Banking

MEDIA:

Logo
Logo